130
Participants
Start Date
October 1, 2018
Primary Completion Date
December 20, 2019
Study Completion Date
December 20, 2019
Triple combination therapy group
Triple oral hypoglycemic therapy based on metformin, dapagliflozin plus saxagliptin.
Premixed insulin therapy group
Subcutaneous injection therapy with insulin aspart 30 in patients with T2DM
The Pearl River Hospital of Southern Medical University, Guangzhou
The Sixth Affiliated Hospital of Guangzhou Medical University
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Peking University Shenzhen Hospital
OTHER
Dongguan Kanghua Hospital
OTHER
First People's Hospital, Shunde China
OTHER
The First Affiliated Hospital of Guangdong Pharmaceutical University
OTHER
The Fifth Affiliated Hospital of Zunyi Medical College
OTHER
Shenzhen Sixth People's Hospital
OTHER
Zhujiang Hospital
OTHER